Matinas BioPharma Holdings, Inc. Marketable Securities, Current in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Matinas BioPharma Holdings, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2019 to Q3 2024.
  • Matinas BioPharma Holdings, Inc. Marketable Securities, Current for the quarter ending September 30, 2024 was $500K, a 95.8% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Matinas BioPharma Holdings, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $500K -$11.3M -95.8% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $10.1M -$2.67M -20.9% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $7.04M -$12.1M -63.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $8.97M -$13M -59.1% Dec 31, 2023 10-K 2025-04-15
Q3 2023 $11.8M -$10.1M -46% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $12.8M -$15.3M -54.6% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $19.1M -$5.42M -22.1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $21.9M -$6.66M -23.3% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $21.9M -$7.03M -24.3% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $28.1M -$1.39M -4.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $24.5M -$12.7M -34.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $28.6M -$17.7M -38.2% Dec 31, 2021 10-K 2023-03-15
Q3 2021 $28.9M -$26.8M -48.1% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $29.5M -$23.6M -44.4% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $37.3M -$23.8M -39% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $46.2M +$40.6M +725% Dec 31, 2020 10-K/A 2022-03-11
Q3 2020 $55.7M Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $53.1M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $61.1M Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $5.6M Dec 31, 2019 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.